Q2FY22 revenue & PAT grew by 45% & 117% YoY, supported by healthy growth across all segments. Gross margin declined by 400bps YoY, but fall in EBITDA margins was limited to 10bps YoY to 12.8%, owing to cost rationalization. Overall, demand scenario improved largely due to pent-up demand,...